Active-ingredient Dossier

Leuprorelin Acetate

Active-ingredient Dossier for Leuprorelin Acetate (gonadotropin releasing hormone agonist). Australian brands, products, PBS listings, PBAC outcomes —…

Brand: BI ELIGARD CP
Brand: ELIGARD
Brand: LUCRIN DEPOT
Therapeutic area: Oncology

What is

Leuprorelin Acetate Leuprorelin Acetate is a gonadotropin releasing hormone agonist.

Australian brands containing

Leuprorelin Acetate — ELIGARD — LUCRIN DEPOT — LERIN

Therapeutic areas

Leuprorelin Acetate is registered in oncology, with three brands containing the ingredient.

Sponsor landscape

Three sponsors market leuprorelin acetate in Australia: Mundipharma, Sandoz, and AbbVie.

PBS and regulatory activity

Two brands containing leuprorelin acetate have PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome was recorded on 1 November 2024, and the latest AusPAR was issued on 6 July 2022.